Bridgebio Pharma Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Bridgebio Pharma Inc inventory turnover ratio, the Bridgebio Pharma Inc 's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.16 in the second quarter 2026, a new company high. Average inventory processing period, for the Bridgebio Pharma Inc in Jun 30 2026 quarter, has decreased to 315 days, compare to 332 days, in the Mar 31 2026 quarter.

Within Healthcare sector 298 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1034 in the first quarter 2026, to 1814.

BBIO Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Bridgebio Pharma Inc Market Share?

What is Inventory Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Inventory Turnover▼

None ▼

Inventory Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

BBIO Inventory Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Inventory Growth	189.12 %	734.09 %	-	-	-
Y / Y Cost of Sales Growth	311.88 %	276.62 %	289.01 %	997.49 %	510.87 %
Inventory Turnover Ratio (TTM)	1.16	1.1	1.14	1.28	1.61
BBIO's Total Ranking	# 1814	# 1034	# 1052	# 0	# 0
Average inventory processing period	315	331	320	286	226
Seq. Inventory Growth	60.22 %	23.28 %	9.08 %	34.2 %	362.24 %
Seq. Cost of Sales Growth	51.38 %	22.6 %	23.53 %	79.66 %	38.42 %

Inventory Turnover Ratio Company Ranking
Within:	No.
Major Pharmaceutical Preparations Industry	# 83
Healthcare Sector	# 299
Overall Market	# 1814

Inventory Turnover Ratio Statistics
High	Average	Low
1.16	1.13	1.1
(Jun 30 2026)		(Mar 31 2026)

BBIO Company Profile >> Back to BBIO Efficiency Comparisons >> Compare BBIO Inventory Turnover Ratio to its Competitors

Financial Statements
Bridgebio Pharma Inc 's Inventories	$ 53 Millions	Visit BBIO's Balance sheet
Bridgebio Pharma Inc 's Cost of Revenues TTM	$ 40 Millions	Visit BBIO's Income Statement
What are BBIO's Sales?		Visit BBIO's Sales by Segment

Other Inventory Turnover Ratios
Bridgebio Pharma Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
BBIO's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for BBIO's Competitors
Inventory Turnover Ratio for BBIO's Suppliers
Inventory Turnover Ratio for BBIO's Customers

You may also want to know
BBIO's Sales Growth Rates	BBIO's Pe Price to earnings ratio	BBIO's Receivables Turnover Ratio	BBIO's Stock Quote
BBIO's Net Income Growth Rates	BBIO's Ps Price to Sales ratio	BBIO's Sales per Employee	BBIO's Asset Turnover Ratio
BBIO's Net Margin	BBIO's Pb Price to Book ratio	BBIO's Financial Strength Ratios	BBIO's Dividend Payout Ratio

Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Inventory Turnover Ratio	Cost of revenues at quarter ending Jun 30 2026	Inventories at quarter ending Jun 30 2026
Glaukos Corp	2.06	$ 128.016 Millions	$ 62 Millions
Orasure Technologies Inc	2.05	$ 64.117 Millions	$ 31 Millions
Zomedica Corp	2.05	$ 11.772 Millions	$ 6 Millions
Phibro Animal Health Corporation	2.02	$ 1,004.346 Millions	$ 498 Millions
Waters Corporation	2.00	$ 2,008.498 Millions	$ 1,005 Millions
Clearpoint Neuro Inc	1.96	$ 15.809 Millions	$ 8 Millions
Skinhealth Systems Inc	1.95	$ 96.775 Millions	$ 50 Millions
Retractable Technologies Inc	1.94	$ 33.979 Millions	$ 17 Millions
Intuitive Surgical Inc	1.94	$ 3,676.900 Millions	$ 1,899 Millions
Lifeloc Technologies Inc	1.93	$ 5.381 Millions	$ 3 Millions
Accuray Incorporated	1.93	$ 290.064 Millions	$ 150 Millions
Nature s Sunshine Products inc	1.92	$ 131.811 Millions	$ 69 Millions
Insulet Corporation	1.91	$ 883.000 Millions	$ 462 Millions
Innoviva Inc	1.91	$ 74.000 Millions	$ 39 Millions
Cytek Biosciences Inc	1.90	$ 96.247 Millions	$ 51 Millions
Immucell Corporation	1.89	$ 17.409 Millions	$ 9 Millions
Pacific Biosciences Of California Inc	1.89	$ 101.369 Millions	$ 54 Millions
Safe Pro Group Inc	1.88	$ 1.089 Millions	$ 1 Millions
Rigel Pharmaceuticals Inc	1.88	$ 23.839 Millions	$ 13 Millions
Sunshine Biopharma Inc	1.87	$ 24.637 Millions	$ 13 Millions
Amgen Inc	1.86	$ 11,613.000 Millions	$ 6,244 Millions
Ocular Therapeutix Inc	1.84	$ 6.708 Millions	$ 4 Millions
Trisalus Life Sciences Inc	1.82	$ 6.508 Millions	$ 4 Millions
Halozyme Therapeutics Inc	1.79	$ 292.421 Millions	$ 164 Millions
Seastar Medical Holding Corp	1.78	$ 0.126 Millions	$ 0 Millions
Alpha Pro Tech Ltd	1.76	$ 38.696 Millions	$ 22 Millions
Tenet Healthcare Corp	1.76	$ 605.000 Millions	$ 344 Millions
Tenon Medical Inc	1.76	$ 1.763 Millions	$ 1 Millions
Iradimed Corporation	1.76	$ 20.839 Millions	$ 12 Millions
Utah Medical Products Inc	1.75	$ 14.771 Millions	$ 8 Millions

Date modified: 2026-08-12T19:40:58+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.